PT
Autoridade da Concorrência

Case details

Print
Merger control
Case reference
Ccent/2016/23 - Maxwelton Investments /Atividade farmacêutica da Invent Farma
Acquired
Inke S.A.
Description
Company active in the pharmaceutical sector.
Acquired
Laboratories Lesvi S.L.
Description
Company active in the pharmaceutical sector.
Acquiring
Maxwelton Investments S.L.U.
Description
Private equity management firm.
Sector
  • Extractive and manufacturing Industries
Activity (NACE)
  • C2120 - Manufacture of pharmaceutical preparations
Applicable legislation
Art. 37(1)(a) (Law 19)
Notification thresholds
Market Share threshold
Type of merger
Vertical
Cooperation with sector regulators
Status
Closed
Type of Investigation
Phase 1
AdC’s decision
Non-opposition
Case description
The notified concentration consists of the acquisition of sole control over Atividade farmacêutica da Invent Farma by Maxwelton Investments
Timeline
2016-07-14
2016-06-27
Click here to see your activities